Polycystic Ovary Syndrome: Crossing the Frontiers in Management

Ayesha Ahmad, Tamkin Khan


Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders in women with a heterogeneous clinico-pathologic spectrum characterised by varying degrees of ovulatory dysfunction and clinical and/ or biochemical features of hyperandrogenism. The etiopathogenesis of PCOS remains controversial with multiple genetic variants and environmental factors interacting together to foster development of the spectrum of clinical features. This article explores the evolving concepts of PCOS, focusing on the role of circadian rhythm and white adipose tissue; the role of precision medicine involving interplay of pharmacogenomics, nutrigenomics, chronotherapy and psychotherapy.

International Journal of Human and Health Sciences Vol. 06 No. 04 Oct’22 Page: 362-371 


Polycystic ovarian syndrome, precision medicine, nutrigenomics, pharmacogenomics, chronotherapy

Full Text:


DOI: http://dx.doi.org/10.31344/ijhhs.v6i4.474


  • There are currently no refbacks.

Copyright (c) 2022 Ayesha Ahmad, Tamkin Khan

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.